Role of calcium channels in heavy metal toxicity by Marchetti, Carla
Hindawi Publishing Corporation
ISRN Toxicology
Volume 2013, Article ID 184360, 9 pages
http://dx.doi.org/10.1155/2013/184360
Research Article
Role of Calcium Channels in Heavy Metal Toxicity
Carla Marchetti
Istituto di Biofisica, Consiglio Nazionale delle Ricerche, 16149 Genova, Italy
Correspondence should be addressed to Carla Marchetti; marchetti@ge.ibf.cnr.it
Received 27 November 2012; Accepted 23 December 2012
Academic Editors: R. W. Coppock, R. Konig, and R. Mateo
Copyright © 2013 Carla Marchetti. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The role of voltage-dependent Ca channels (VDCC) in themembrane permeation of two toxicmetals, lead (Pb) and cadmium (Cd),
was studied in mammalian cells. Both metals interact with Ca-binding sites, but, while Cd influx appears to occur mainly through
the same pathways as Ca, Pb is also rapidly taken up by different passive transport systems. Furthermore, I compared the effect
of Cd in two Chinese hamster ovary (CHO) cell lines, a wild-type and a modified cell line, which were permanently transfected
with an L-type VDCC. When cultures were subjected to a brief (30–60min) exposure to 50–100𝜇MCd, apoptotic features, metal
accumulation, and death were comparable in both cell lines although, in transfected cells, the effect of Cd treatment was partially
prevented by nimodipine (VDCC antagonist) and enhanced by BayK8644 (VDCC agonist).Thus, expression of L-type Ca channels
is not sufficient to modify Cd accumulation and sensitivity to a toxicological significant extent and while both Cd and Pb can take
advantage of VDCC to permeate the membrane, these transport proteins are not the only, and frequently not the most important,
pathways of permeation.
1. Introduction
Metals are used by biological systems because of their cat-
alytic versatility, and some of them, namely, sodium (Na),
potassium (K), calcium (Ca), and magnesium (Mg) are
among the essential nutrients of living cells. In contrast, other
metals can be fatal to mammalian cells even in tiny amounts.
A common classification tends to sort these potentially toxic
metals in to two classes: those required by living organisms as
essential micronutrients and those devoid of any biological
function and thus potentially toxic even at very low con-
centration, such as cadmium (Cd), chromium (Cr), mercury
(Hg), and lead (Pb). The difference between toxic and
nontoxic metals is hard to define. Even micronutrients, such
as cobalt (Co), copper (Cu), iron (Fe), manganese (Mn),
molybdenum (Mo), and zinc (Zn) can be detrimental to liv-
ing organisms, when present in excessive levels, and a refined
equilibrium between deficient and toxic concentrations has
to be maintained. This is particularly important for very
specialized tissues, such as the brain, where metals induce
oxidative damage and some of the essential micronutrients,
such as Fe, Zn, and Cu, have been implicated in etiology and
development of different neurological and neurodegenerative
diseases [1, 2]. Less obviously, living organism may find
use for nonessential toxic metals in extreme condition. An
elegant example of unexpected biological function of Cd has
been recently reported in marine diatoms [3].
Because most toxic metals have entered the environment
as a consequence of historical handcraft and industrial pro-
cessing, specialized cellsmight not have developed the intrin-
sic ability to distinguish between physiological and toxic ele-
ments. For example, Cd and Pb represent a threat for mam-
malian cells, because they are able to replace ormimic essen-
tial metals in the first or early step of transport and metab-
olism, but then are incapable of mediating subsequent vital
functions [4, 5]. The toxic effects are then a consequence of
both impairment of transport systems and accumulation into
the cell. Recent research has gathered an increasing body of
evidence for the interaction of toxic metals with intracellular
components that lead to cellular injury and defense, but
the mechanisms of transport of these metals and metal-
containing species across plasma membranes remain to be
fully characterized.
Cd and Pb mimic Ca and Zn at their specific sites and
bind calmodulin [6, 7], protein kinase C [8–10], and synaptic
proteins [11]. These metal ions antagonize Ca influx through
voltage-dependent and receptor-operated Ca channels, and
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these channels are regarded as the major route of their entry
into mammalian cells.
Both Cd and Pb are well-known specific blockers of
voltage-dependent Ca channels (VDCC), but the mechanism
of block is quite different. While Cd binds to the high affinity
site inside the VDCC pore [12, 13], Pb competes with Ca at a
site external to the VDCC, and the binding is not voltage-
dependent [14]. Given these differences in the mechanism
of interaction, permeation of these metals through VDCC
is also different. VDCCs mediate Cd influx in excitable cells
[15–18], including mammalian neurons [19], and have been
proposed to participate in Cd uptake also in cells from
nonexcitable tissues [20]. In a previouswork ofmy laboratory,
we showed that in certain cells Cd permeation occurs mainly
through VDCC of the L-type [19, 21]. However, in other
studies, the presence of VDCC per se did not seem to enhance
sensitivity to Cd; for example, VDCCs expressing (PC12) and
nonexpressing (PC18) cells showed comparable LD
50
for Cd
[18], and the role of this pathway in the induction of cell death
appears questionable.
The situation is even more complicated for Pb, whose
chemical basis formimickingCa is not obvious [4] andwhich
is known to adapt to structurally diverse binding geometries
[22]. In cerebellar granule neurons, Pb uses at least three
pathways of permeation and besides voltage-dependent cal-
cium channels (VDCC) and NMDA-activated channels, is
rapidly taken up through passive transport system [23, 24].
In this paper I will present experimental evidence con-
cerning transport of Pb and Cd across cellular membranes
and the relative contribution of VDCC in their uptake.
2. Materials and Methods
2.1. Cell Culture. Cerebellar granule neurons were prepared
from 8-day-old Wistar rats as previously described [19, 25],
plated on 20mm poly-L-lysine coated glass coverslips and
maintained in basal Eagle’s culture medium, supplemented
with 10% fetal calf serum, 100 𝜇g/mL gentamicin and 25mM
KCl, in a humidified 95% air/CO
2
atmosphere at 37∘C.
Cultures were treated with 10 𝜇M cytosine arabinoside from
day 1 to minimize the proliferation of nonneuronal cells.
Experiments were carried out in cultures between 5 and 13
days in vitro.
Wild-type Chinese hamster ovary (CHO) cells were ob-
tained from American Type Culture Collection. CHO stably
transfected with cDNA encoding for several subunits of
voltage-dependent calcium channels (VDCC) were a gener-
ous gift of Franz Hofmann and Norbert Klugbauer (Institut
fu¨r Pharmakologie und Toxikologie, Mu¨nich, Germany).
The cells used in this study are termed CHOC𝛼9𝛽
3
𝛼
2
/𝛿4
(abbreviated CHOC𝛼) to indicate that they express the 𝛼
1𝐶−𝑏
subunit of VDCC, as well as 𝛽
3
and 𝛼
2
/𝛿4 subunits from
smooth muscle [26].
Both wild-type CHO and CHOC𝛼 cells were maintained
in DMEM medium (Sigma Chemical Co, St. Louis, MO,
USA) supplemented with 10% bovine serum, in a 5% CO
2
humidified atmosphere at 37∘C. For CHOC𝛼 cells, the cul-
ture medium was routinely supplemented with antibiotic
geneticin G418 20𝜇gr/mL. For the experiments, cells were
plated in 12-multiwell trays at a density of 2 × 105 cells/mL.
2.2.Microscopy. Measurement of intracellular Cd and Pbwas
performed on monolayer cultures plated on glass coverslips.
For photometric measurements, cells were incubated with
6 𝜇M of the cell-permeant Fura2-AM ester form of the dye
for 45min at 37∘C and then washed several times with
standard saline at room temperature, as previously described
[19, 23]. Cd and Pb were applied in the absence of Ca
and treatment was terminated by the addition of the
membrane-permeant metal chelator (N,N,N󸀠,N󸀠-tetrakis-2-
pyridyl methyl ethylenediamine, TPEN, 100 𝜇m).
For confocal microscopy, cells were incubated with Ore-
gonGreen 488Bapta-1, a fluorescent indicator, whose fluores-
cence intensity is increased upon binding Ca, Cd, or Pb. Cells
were imaged using a confocal laser scanning microscope
Nikon PCM2000 (Nikon Instr., Florence, Italy) with an oil
immersion 100 × objective (Na = 1.3), coupled to a 50𝜇m
confocal pinhole condition [27].
2.3. Cd Treatment. Cells were subjected to 30–60min treat-
ments with 50 or 100𝜇M CdCl
2
in culture medium without
serum. When specified, the medium was supplemented with
30mM KCl to depolarize the cell membrane and with the
following dihydropyridines (DHPs) : BayK 8644, which is an
L-type VDCC agonist, or nimodipine, a channel antagonist.
Stock solutions of nimodipine and BayK (10mM) were
made up in 100% ethanol and diluted in medium to the
final concentration. High KCl alone, as well as DHPs (no
Cd added), had no effect on cell viability and appearance.
After incubation cells were washed three times with PBS
containing 1mMEDTA, and freshmedium containing serum
was replaced. Cultures were kept in the incubator for another
18–24 hours before testing. Cell viability in each sample
was assessed by trypan-blue exclusion assay. All chemicals,
culture media and sera, were from Sigma-Aldrich Italy.
2.4. Capacitance and Current Measurements by Patch-Clamp
Technique. Membrane currents were measured from wild-
type CHO and permanently transfected CHOC𝛼 cells in
whole-cell clamp configuration by a patch-clamp Axopatch
amplifier (Molecular Devices Corporation, Union City, CA,
USA). Electrodes were manufactured from borosilicate glass
capillaries (Hilgenberg GmbH, Malsfeld, Germany) and had
resistance of ≈ 4MΩ. Voltage stimulation and data acqui-
sition were performed by a PC through a Digidata 1440A
interface and Pclamp-10 software (Molecular Devices). Cur-
rents were low-pass filtered at 5 kHz and digitized at 10 kHz.
Capacitance transients wereminimized by analog compensa-
tion, and the value obtained by this compensation was taken
as an estimate of the cell capacitance. All currents traces
were further corrected for leak and residual transients by a
computer generated P/4 protocol. The holding potential was
−80mV in all the experiments. Current traces were analyzed
with Clampfit-10 and Sigma Plot (Jandel Scientific, Erkrath,
Germany) software.
Cells were continuously superfused by gravity flow
(10mL/min) with a solution containing (in mM) NaCl 140,
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KCl 5.4, CaCl
2
1.8, Hepes 5. The pH was 7.4. The internal
(pipette) solution contained (in mM): CsCl 20, CsOH 110,
Aspartic acid 100, EGTA 5, Hepes 5, with pH adjusted
to 7.3 with Trizma base. Calcium currents were recorded
in similar external solution containing 130mM NaCl and
5mMCaCl
2
. Wild-type CHO cells do not possess prominent
voltage-dependent currents, and CHOC𝛼 only contained the
L-type VDCC under study; therefore there was no need
to antagonize the current through other voltage-dependent
channels to resolve Ca currents.The application of modifiers,
such as agonist and antagonist DHPs, was accomplished by
gravity flow; control ion substitution experiments showed
that the external bathwas completely changed in 10 sec, which
was the maximal stimulation rate in these experiments.
2.5. Absorption Spectroscopy Cd Determination. Cells were
exposed to Cd in culture medium without added serum.
After treatment, cultures were washed three times with PBS
containing 1mM EDTA and harvested immediately. Viable
cells were counted in triplicate in each sample. Cells were then
washed again three times with the above buffer, resuspended
in distilled water and disrupted by sonication (Sonopuls
Ultrasonic Homogenizer, Bandelin) for 2 minutes in an ice
bath. The total Cd content of each sample was measured by
Flameless Atomic Absorption Spectroscopy (FAAS) using a
Perkin Elmer Spectrophotometer (Model 1100 B) equipped
with a graphite furnace (Model HGA 700). The Cd content
was normalized to the volume occupied by the cells and
molarity was calculated (see results).
2.6. Statistical Analysis. Data are presented as mean ± stan-
dard error of the mean in at least 3 experiments. Statistical
significance was evaluated by Student-Newman-Keuls multi-
ple comparison test (In Stat, GraphPad Software).
3. Results And Discussion
3.1. Influx of Toxic Metals into Mammalian Cells. Influx
of toxic divalent metal ions into mammalian cells can be
monitored in cells preloaded with specific fluorescent probes,
Fura2 [17, 19, 23], or Oregon green. These fluorescent indica-
tors were developed and are predominantly used for deter-
mining intracellular calcium levels, but they have relatively
high affinity also for other polyvalent ions, including Cd and
Pb.
Figure 1 shows how exposure to a solution containing a
toxicologically significant concentration of Cd or Pb causes
a sizeable increase in Oregon Green fluorescence, similar to
that seen following Ca influx [28]. This demonstrates fea-
sibility of this probe as toxic metal influx indicator. In this
experiment, while Cd uptakewas triggered by depolarization,
indicating the essential contribution of VDCC (Figure 1(A)
(a)-(b)), neurons rapidly accumulate Pb even in the absence
of a specific stimulus (Figure 1(A) (c)-(d)).
Figure 1(B) shows real-time measurements of Cd and
Pb influx in Fura2-loaded neurons [19, 23]. The influx was
quantified by measuring the fluorescence emission ratio R
(E
380
/E
340
), and membranes were depolarized by increasing
concentration of external KCl [25]. In the left panel, the
fluorescent ratio, E
340
/E
380
, increased negligibly when 50𝜇M
Cd was applied in resting condition, but the rate of rise,
dR/dt, was enhanced by >60 times following depolarization
with 25KCl. In contrast, Pb (15–50𝜇M)determined a sizeable
increase of R even in the absence of any specific stimulus that
opens VDCC, and dR/dt was increased by 5 times from the
resting level with 75mMKCl (Figure 1(C)). Fast uptake of Pb
in the absence of any specific stimulus appears to be a peculiar
feature of neurons and may be linked to the specific lipidic
composition of the neuronal membranes, while the role of
VDCC is likely to significant, but not essential [23].
3.2. Role of VDCC in Cd-Induced Mortality. As VDCC chan-
nels, and in particular those of L-type [15, 19] play a promi-
nent role in uptake of Cd by excitable cells, the involvement of
these channels in Cd toxicity was investigated further. Tests of
mortality, chromatin condensation, and DNA fragmentation
showed that a pulsed Cd treatment induces delayed apop-
totic cell death in VDCC-containing insulinoma cells and
that nimodipine protects against Cd-induced apoptosis and
necrosis in these cells, supporting a specific involvement of L-
type VDCC [21]. The same treatments were largely harmless
in VDCC-free HeLa cell cultures, in which neither death nor
DNA fragmentation was observed. Therefore, excitable cells
appear more susceptible than nonexcitable epithelial-like
cells to Cd accumulation. However, it is not clear whether the
mere presence of VDCC can make cells more vulnerable to
toxicmetal injury. To answer this question we have compared
the effects of Cd in two cell types that are virtually identical,
except for the expression of VDCC in one of the two. This
approach is made possible by the availability of a CHO cell
line that has been permanently transfected with VDCC 𝛼
1
,
𝛽, and 𝛼
2
/𝛿 subunits, CHOC𝛼9𝛽
3
𝛼
2
/𝛿
4
cells [26, 29]. Promi-
nent voltage-dependent Ca currents were recorded from
the permanently transfected cell line, while such currents
are completely absent in wild-type CHO (Figure 2(a)). The
currents are larger with Ba as charge carrier and are sensitive
to DHP modulation (Figure 2(b)), as expected for an L-type
Ca channel.
Both cell types (wild-type and CHOC𝛼) were subjected
to a “pulse treatment” with 50 or 100 𝜇M Cd in serum-free
culture medium and observed after 18–24 hour after wash.
Cell suffering and mortality was negligible immediately after
the treatment, but it was evident after at least 16 hours. As
previously observed [21, 30, 31], Cd accumulates into the cell
during treatment, but the toxic mechanism leading to cell
death becomes effective at a later time. Figure 3 shows the
appearance of the cell monolayer 24 hours after an incubation
of 30min with 100𝜇M Cd. Cells exposed to Cd were of
smaller size than control cells and had an increased tendency
to detach from their neighbors and from the substrate and
float. In addition, CHOC𝛼VDCC-expressing cells frequently
acquired an irregular shape, with shredded edges (Figure 3).
The number of viable cells was estimated from the number
of adherent, trypan-blue excluding cells, and this number
was normalized to that of adherent viable cells in control
conditions, as in our previous works [21]. Despite some mor-
phological features, the dose dependence of Cd sensitivity
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Figure 1: Uptake of Cd and Pb in cerebellar granule neurons measured by fluorescent dyes. (A) Confocal microscopy images of Cd (a, b) and
Pb (c, d) uptake by cerebellar granule cells preloaded with the divalent metal-sensitive dye Oregon Green. In (a) and (c), neurons were bathed
in a physiological saline. In (b) they have been superfused with a solution containing 0 Ca, 30mM KCl and 100 𝜇M Cd Cl
2
, which caused
the dye fluorescence to increase significantly. In (d), external solution contained 0Ca and Pb 15𝜇M, which permeates through the neuron
membrane even in the absence of a depolarizing stimulus and also caused an increase in the dye fluorescence. Bar = 10 𝜇M. (B) Real-time
recording of the influx of Cd and Pb in Fura-2 loaded cerebellar granule neuron and the effect of membrane depolarization. Cells were treated
with the metals in nominal Ca-free solution. From left to right: time course of the fluorescence ratio, 𝑅 = E340/E380, following application of
50 𝜇MCd and membrane depolarization (25mM KCl) and application of 15–50𝜇M Pb in resting conditions and increasing depolarizations
(25 and 75mM KCl). (C) Summary of the results obtained in basal and in depolarizing solutions (25 and 75mM KCl) with different doses of
Pb. The time course of R(t) was approximated by a straight line and the slope dR/dt was calculated in each case, as a measure of Pb influx.
Data are mean ± SEM in 4 experiments and ∗indicates significantly different from basal (no depolarization) for each dose of Pb (𝑃 < 0.05).
was very similar in the two cell types (Figure 3). Therefore,
by this approach it is not possible to demonstrate a clear role
of VDCC in mediating Cd-induced cell detachment.
In subsequent experiments, we challenged the cells with
Cd in the presence of 1𝜇M DHP modifiers. When VDCC-
expressing CHOC𝛼 cells were exposed to Cd in the presence
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Figure 2: CHOC𝛼 cells express L-type VDCC. (a) Representative microphotographs of monolayer cell cultures of permanently transfected
CHOC𝛼 cells (left) and wild-type CHO cells (right). Bar = 35 𝜇M. (b) Representative current traces evoked by depolarizing voltage steps
of 40ms duration from −60 to +80mV from a holding potential of −80mV in a CHOC𝛼 cell (left) and a wild-type CHO cell (right). The
external solution contained 5mMCaCl
2
. This protocol evoked voltage-dependent calcium current in the permanently transfected cell, while
no current was present in CHO cell of the wild-type. (c) Characterization of the Ca current in CHOC𝛼 cell.The current was increased bymore
than 50% when the external solution was changed from 5mM CaCl
2
to 5mM BaCl
2
, and it was reversibly blocked by 10 𝜇M nimodipine.
Current traces evoked by 50ms depolarizing steps from −80mV (holding potential) to +10mV in the three conditions are shown on the left.
The graph on the right shows the time course of the experiment.
of the antagonist (nimodipina) or agonist (BayK 8644), the
effect of the metal was clearly modified with respect to cells
exposed to Cd alone (Figure 4), with a sizeable increase of
mortality in the presence of BayK and protection in the pres-
ence of nimodipine.DHPmodifierswere largely ineffective in
wild-type CHO cells exposed to Cd (not shown). Therefore,
it seems that the actual contribution of L-type VDCC to Cd
uptake is clearly underscored only in the presence of these
modifiers.
Another indicator of apoptosis is cell shrinkage, which
can be quantified by cell capacitance measurements. Both
wild-type and CHOC𝛼 cells showed a decrease in cell capaci-
tance 18–24 hours afterCd treatment. Inwild-type, cell capac-
itance was 24±2 pF (𝑛 = 15) in control and 15± 3 pF (𝑛 = 6)
after incubation with 100 𝜇MCd, significantly different from
control with 𝑃 < 0.05. In CHOC𝛼 cells, cell capacitance was
35 ± 3 pF (𝑛 = 17) in control and 22 ± 2 pF (𝑛 = 39)
after incubation with 100 𝜇MCd, significantly different from
control with 𝑃 < 0.001. In CHOC𝛼 cells, the effect of
Cd treatment was partially prevented by nimodipine: the
capacitance was 35±3 pF (𝑛 = 10) and the difference between
this condition and control condition was not significant
(Figure 5).This indicates again that the contribution of L-type
VDCC in Cd-induced toxicity is evident only in the presence
of DHPs.
Finally, we performedmeasurements of total Cd accumu-
lation during 60min incubation time by atomic absorption
spectroscopy. For these experiments, cells were harvested
immediately after the treatment, and the total amount of Cd
was normalized to the cell volume, estimated from the single-
cell capacitance. Assuming that both cell types are approxi-
mately spherical and have a specific membrane capacitance
of 1 𝜇F/cm2, 106 wild-type CHO cells comprise a volume of
11 𝜇L, while 106 CHOC𝛼 cells a volume of 19.5𝜇L. This
difference is not negligible, and with this method, the results
were considerably more reproducible than using a standard
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Figure 3: Effect of pulse treatment with Cd in CHOC𝛼 VDCC-expressing and wild-type CHO cells. Microphotographs of control (a, b) and
Cd-treated (c, d) cells: (a, c) VDCC-expressing CHOC𝛼 cells and (b, d) wild-type CHO cells. Both cell types were incubated in 100𝜇M Cd
for 60 minutes in the presence of 30mM KCl. Pictures were taken 24 h after wash of the metal. Bar = 35 𝜇M.The graph (e) shows the effect
of a 30min pulse treatment with Cd on cell adhesion, as a function of concentration. Trypan-blue excluding adherent cells were counted
24 h after wash of the metal. Points are average ± sem of 3 experiments in the same condition in CHOC𝛼 (filled circles) and wild-type CHO
(empty circles) and were best fitted to the function. Nadher/Nadher(control) = 1/(1 + ([Cd]/ED50)), where Nadher/Nadher(control) is the number of
adherent cells after Cd treatment normalized to the number of adherent cells in control culture; [Cd] is the concentration of Cd and ED
50
is
the concentration of Cd that causes detachment from the substrate of 50% of cells. The best fit yielded ED
50
= 40 𝜇M for CHOC𝛼 and 43𝜇M
for wild-type CHO.The two curves are overlapped. In contrast with the different appearance, the two cell types were similarly affected by Cd
treatment.
normalization to the total protein content. Data shown in
Figure 6 indicate that the difference in Cd accumulation is
barely or not significant when both cell types are incubated
in 100𝜇M Cd with or without elevated KCl. On the other
hand, BayK 8644 significantly enhanced and nimodipine
significantly decreased metal accumulation in depolarized
CHOC𝛼 cells treated with 50 or 100𝜇M Cd, but not in wild-
type CHO cells.
Toxicity of both Cd and Pb is mainly due to their ability
to permeate not simply mammalian cell membranes, but
specifically tight membrane barriers, such as the epithelial
lining in the gastrointestinal tract, luminal membrane of
proximal tubules in the kidney, and the blood-brain barrier.
In early work, the influx of Pb and Cd into mammalian
cells was frequently ascribed to permeation through calcium
channels, and in particular L-type DHP-sensitive VDCC [16,
18, 20, 32].More recently other types of VDCC, different from
the classical DHP-sensitive L-type, have been implicated both
in Cd [19, 33] and Pb [23] uptake. Moreover, Pb has been
shown to use different pathways in several systems [34–37],
and it is largely independent of VDCC even in neurons
[23, 24].
Here I have shown that expression of L-type VDCC is not
sufficient to modify Cd uptake to a toxicological significant
extent, at least in the case of a brief, intense exposure, as
those used in this study. Cd accumulation and sensitivitywere
comparable in two cell lines whose only difference was the
presence of L-typeVDCC in one of the two. Indeed,wild-type
CHO cells, which do not possess VDCC, are vulnerable to Cd
poisoning and take up Cd during relatively brief exposures
to an extent sufficient to trigger cell death by apoptosis
or necrosis similarly to VDCC expressing CHOC𝛼 cells.
Although VDCCs play an important role in Cd uptake
in CHOC𝛼 cells, as indicated by the sizeable effect of L-
type channel DHP modifiers, wild-type CHO cells use other
transport proteins with similar efficiency and outcome.
It is thus clear that VDCCs are not the main mecha-
nism responsible for toxic metal permeation through cell
membranes and tight barriers. Rapid passive transport of Pb,
independent of VDCC, was reported at the brain endothe-
lium [34, 36, 37], and even protein-independent transport
of lead has been described [35]. In astroglia cell models, the
uptake of Pb was shown to be driven by store-depletion-
activated channels [38] and by two distinct pH-sensitive
transport mechanisms [39]. VDCC-independent uptake of
Pb by cerebellar granule neurons was inhibited by La [24],
and this observation can provide some clue as for the mecha-
nism of permeation.The involvement of a La-sensitive store-
depletion activated channel, as proposed in other systems
[36, 37, 40], is unlikely because Pb influx did not require
drainage of the stores. Another possibility is that Pb2+ enters
the neuron via reverse operation of an exchanger similar (or
identical) to theNa–Ca exchanger, which is also very sensitive
to La block [41] and whose role in Zn permeation was
demonstrated in cortical neurons [42]. Also this possibility
was discarded because Na–Ca exchanger does not play
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Figure 4: Effect of dihydropyridines on Cd cytotoxicity in VDCC-expressing CHOC𝛼 cells. Cells were treated for 30min in (a) control
mediumcontaining 30mMKCl, (b) 100 𝜇M Cd+30mM KCl, (c) 100 𝜇M Cd+30mM KCl+1 𝜇Mnimodipine, (d) 100 𝜇M Cd+30mM KCl+
1 𝜇M BayK8644. Note the partial recovery in shape of the cells treated in the presence of nimodipine and definitive lost of adhesion when
the treatment was performed in the presence of BayK. Bar = 25 𝜇M. The graph (e) represents counts of viable adherent cells in the same
experiment (average ± sem in 3 samples) in control (basal), following for a 30min treatment with 100 𝜇M Cd (Cd), Cd + 30mM KCl (K),
Cd + 30mM KCl and 1 𝜇M nimodipine (N), and Cd + 30mM KCl and 1 𝜇M BayK (B). ∗ indicates significantly different from control with
𝑃 < 0.05, and ∗∗ with 𝑃 < 0.0001.
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Figure 5: Evidence of Cd-induced apoptosis: change in cell capac-
itance. Cells were incubated with 100𝜇M Cd for 60 minutes, and
electrical measurements were performed 24 h after wash. Mem-
brane capacitance was estimated from transient compensation (see
Section 2.4). Bars represent mean ± sem. Treatment with Cd caused
shrinkage of all cell, as revealed by reduction of the cell capacitance
in both wild-type (𝑛 = 15 in control and 𝑛 = 6 with Cd treatment)
and CHOC𝛼 cells (𝑛 = 17 in control and 𝑛 = 39with Cd treatment).
Nimodipine protected CHOC𝛼 cells from Cd-induced shrinkage
(𝑛 = 10). ∗ indicates significantly different from control with 𝑃 <
0.05, and ∗∗ with 𝑃 < 0.001.
a significant role when the Na concentrations are close to
the physiological value, as in Esposito et al. [24]. It is more
probable that Pb is taken up through a La-sensitive ion carrier
similar to the Zn transporter found in brain neurons [43],
whose identity and features still wait full definition.
Involvement of different transport proteins in Cd trans-
port has been described. At the epithelial lining of the gas-
trointestinal barrier, DMT1, the main transporter that
absorbs Fe in the brush border membrane of the mammalian
intestine has been shown to carry also different toxic metals
[44–46]. The role of this transporter in Cd absorption is
underscored by the fact that iron deficiency creates a sig-
nificant risk for increased cadmium exposure by increasing
gastrointestinal absorption from 5% to as much as 20%.
In general, a low level of essential metals favors uptake of
nonessential (toxic) elements that compete for their site, and
this stresses the importance of evaluating metal balance, in
contrast with metal concentration. In addition, other metal-
specific transporters have been identified at the cDNA level
[47] and studied in expression systems [48].
4. Conclusion
Ionicmimicry is a useful framework to study themechanisms
of metal toxicity. Uptake of toxic metals, such as Cd and Pb,
by mammalian cells of different tissues occurs through many
different pathways, of which VDCCs have frequently been
regarded as prominent. Because of the abundance of VDCC,
excitable cells may be more susceptible to accumulate Cd
and Pb than nonexcitable cells. In this chapter I have shown
that although Cd and Pb can permeate through VDCC, this
is not the most relevant mechanism of passive uptake of
Pb, while the mere presence of VDCC is not sufficient to
make cells significantly more vulnerable to Cd injury. Other
factors, including different transport systems and expression
of detoxification proteins, may be more relevant in the accu-
mulation process of these toxic metals.
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Figure 6: Total Cd accumulation measured by FAAS in CHOC𝛼
and wild-type CHO cells. Both cell types were incubated for 1 hour
in medium containing 0, 50, or 100 𝜇M Cd and other modifiers.
Cd determination was normalized to the cell volume (see text).
Treatments were as follows: control 0 Cd (basal), 60min Cd (Cd),
Cd + 30mM KCl (K), Cd + 30mM KCl, and 1𝜇M BayK (B), Cd +
30mM KCl and 1𝜇M nimodipine (N). Depolarization (treatment
K) did not increase significantly the intracellular concentration of
Cd (𝑃 > 0.05). In CHOC𝛼 cells, but not in wild-type CHO, BayK
significantly enhanced and nimodipine significantly reduced Cd
accumulation, both with 𝑃 < 0.001 (∗), with respect to the same
treatments in depolarization. Bars represent mean ± sem in at least
10 experiments in each group.
Acknowledgments
The author thanks Ilaria Zanardi and Irena Baranowska-
Bosiacka (PUM, Szczecin, Poland) for help in Cd treatment
experiments and Elisabetta Morelli for FAAS measurements.
The author is also grateful to Franz Hofmann and Norbert
Klugbauer (Institut fu¨r Pharmakologie und Toxikologie,
Mu¨nich, Germany) for their permission to use the perma-
nently transfected CHO cells and to Maurizio Taglialatela
and Mauro Cataldi (Universita` Federico II, Naples, Italy) for
sending him the cells.
References
[1] R. J. Castellani, P. I.Moreira, G. Liu et al., “Iron: the redox-active
center of oxidative stress in Alzheimer disease,” Neurochemical
Research, vol. 32, no. 10, pp. 1640–1645, 2007.
[2] D. G. Smith, R. Cappai, and K. J. Barnham, “The redox chem-
istry of the Alzheimer’s disease amyloid 𝛽 peptide,” Biochimica
et Biophysica Acta, vol. 1768, no. 8, pp. 1976–1990, 2007.
[3] Y. Xu, L. Feng, P. D. Jeffrey, Y. Shi, and F.M.M.Morel, “Structure
and metal exchange in the cadmium carbonic anhydrase of
marine diatoms,” Nature, vol. 452, no. 7183, pp. 56–61, 2008.
[4] T. W. Clarkson, “Molecular and ionic mimicry of toxic metals,”
Annual Review of Pharmacology and Toxicology, vol. 33, pp.
545–571, 1993.
[5] C. C. Bridges and R. K. Zalups, “Molecular and ionic mimicry
and the transport of toxic metals,” Toxicology and Applied
Pharmacology, vol. 204, no. 3, pp. 274–308, 2005.
[6] H. Ouyang and H. J. Vogel, “Metal ion binding to calmodulin:
NMRand fluorescence studies,”BioMetals, vol. 11, no. 3, pp. 213–
222, 1998.
[7] M. Kern,M.Wisniewski, L. Cabell, andG. Audesirk, “Inorganic
lead and calcium interact positively in activation of calmod-
ulin,” NeuroToxicology, vol. 21, no. 3, pp. 353–364, 2000.
[8] J. Markovac and G.W. Goldstein, “Picomolar concentrations of
lead stimulate brain protein kinase C,”Nature, vol. 334, no. 6177,
pp. 71–73, 1988.
[9] X. Sun, X. Tian, J. L. Tomsig, and J. B. Suszkiw, “Analysis
of differential effects of Pb2+ on protein kinase C isozymes,”
Toxicology and Applied Pharmacology, vol. 156, no. 1, pp. 40–45,
1999.
[10] J. L. Tomsig and J. B. Suszkiw, “Multisite interactions between
Pb2+ and protein kinase C and its role in norepinephrine release
from bovine adrenal chromaffin cells,” Journal of Neurochem-
istry, vol. 64, no. 6, pp. 2667–2673, 1995.
[11] C. M. Bouton, L. P. Frelin, C. E. Forde, H. A. Godwin, and J.
Pevsner, “Synaptotagmin I is amolecular target for lead,” Journal
of Neurochemistry, vol. 76, no. 6, pp. 1724–1735, 2001.
[12] J. Yang, P. T. Ellinor, W. A. Sather, J. F. Zhang, and R. W. Tsien,
“Molecular determinants of Ca2+ selectivity and ion permeation
in L-type Ca2+ channels,”Nature, vol. 366, no. 6451, pp. 158–161,
1993.
[13] M.Wakamori, M. Strobeck, T. Niidome, T. Teramoto, K. Imoto,
and Y. Mori, “Functional characterization of ion permeation
pathway in the N-type Ca2+ channel,” Journal of Neurophysiol-
ogy, vol. 79, no. 2, pp. 622–634, 1998.
[14] S. Peng, R. K. Hajela, and W. D. Atchison, “Characteristics of
block by Pb2+ of function of human neuronal L-, N-, and R-
type Ca2+ channels transiently expressed in human embryonic
kidney 293 cells,” Molecular Pharmacology, vol. 62, no. 6, pp.
1418–1430, 2002.
[15] C.Usai, A. Barberis, L.Moccagatta, andC.Marchetti, “Pathways
of cadmium uptake in excitable mammalian cells: a microspec-
trofluorimetric study,” European Journal of Histochemistry, vol.
41, pp. 189–190, 1997.
[16] P. M. Hinkle, P. A. Kinsella, and K. C. Osterhoudt, “Cadmium
uptake and toxicity via voltage-sensitive calcium channels,”
Journal of Biological Chemistry, vol. 262, no. 34, pp. 16333–16337,
1987.
[17] P. M. Hinkle, E. D. Shanshala, and E. J. Nelson, “Measurements
of intracellular cadmium with fluorescent dyes—further evi-
dence for the role of calcium channels in cadmium uptake,”The
Journal of Biological Chemistry, vol. 267, pp. 25553–25559, 1992.
[18] P. M. Hinkle and M. E. Osborne, “Cadmium toxicity in rat
pheochromocytoma cells: studies on themechanism of uptake,”
Toxicology and Applied Pharmacology, vol. 124, no. 1, pp. 91–98,
1994.
[19] C.Usai, A. Barberis, L.Moccagatta, andC.Marchetti, “Pathways
of cadmium influx in mammalian neurons,” Journal of Neuro-
chemistry, vol. 72, no. 5, pp. 2154–2161, 1999.
[20] V. Souza, L. Bucio, andM.C.Gutie´rrez-Ruiz, “Cadmiumuptake
by a human hepatic cell line (WRL-68 cells),” Toxicology, vol.
120, no. 3, pp. 215–220, 1997.
[21] P. Gavazzo, E. Morelli, and C. Marchetti, “Susceptibility of
insulinoma cells to cadmiumandmodulation by L-type calcium
channels,” BioMetals, vol. 18, no. 2, pp. 131–142, 2005.
[22] M. Kirberger and J. J. Yang, “Structural differences between
Pb2+- and Ca2+-binding sites in proteins: implications with
ISRN Toxicology 9
respect to toxicity,” Journal of Inorganic Biochemistry, vol. 102,
no. 10, pp. 1901–1909, 2008.
[23] M.Mazzolini, S. Traverso, andC.Marchetti, “Multiple pathways
of Pb2+ permeation in rat cerebellar granule neurones,” Journal
of Neurochemistry, vol. 79, no. 2, pp. 407–416, 2001.
[24] A. Esposito, M. Robello, F. Pellistri, and C. Marchetti, “Two-
photon analysis of lead accumulation in rat cerebellar granule
neurons,” Neurochemical Research, vol. 30, no. 8, pp. 949–954,
2005.
[25] C. Marchetti, C. Amico, and C. Usai, “Functional characteriza-
tion of the effect of nimodipine on the calcium current in rat
cerebellar granule cells,” Journal of Neurophysiology, vol. 73, no.
3, pp. 1169–1180, 1995.
[26] A. Welling, E. Bosse, A. Cavalie et al., “Stable co-expression of
calcium channel 𝛼1,𝛽 and 𝛼2/𝛿 subunits in a somatic cell line,”
Journal of Physiology, vol. 471, pp. 749–765, 1993.
[27] A. Diaspro, S. Annunziata, M. Raimondo, P. Ramoino, and M.
Robello, “A single-pinhole confocal laser scanning microscope
for 3-D imaging of biostructures,” IEEE Engineering inMedicine
and Biology Magazine, vol. 18, no. 4, pp. 106–110, 1999.
[28] F. Pellistri, A. Cupello, A. Esposito, C. Marchetti, and M.
Robello, “Two-photon imaging of calcium accumulation in rat
cerebellar granule cells,” NeuroReport, vol. 15, no. 1, pp. 83–87,
2004.
[29] M. Cataldi, A. Secondo, A. D’Alessio et al., “Studies on
maitotoxin-induced intracellular Ca2+ elevation in chinese
hamster ovary cells stably transfected with cDNAs encoding
for L-type Ca2+ channel subunits,” Journal of Pharmacology and
Experimental Therapeutics, vol. 290, no. 2, pp. 725–730, 1999.
[30] A. Gala´n, A. Troyano, N. E. Vilaboa, C. Ferna´ndez, E. De
Blas, and P. Aller, “Modulation of the stress response during
apoptosis and necrosis induction in cadmium-treated U-937
human promonocytic cells,” Biochimica et Biophysica Acta, vol.
1538, no. 1, pp. 38–46, 2001.
[31] A. H. B. Poliandri, J. P. Cabilla, M. O. Velardez, C. C. A.
Bodo, and B. H. Duvilanski, “Cadmium induces apoptosis in
anterior pituitary cells that can be reversed by treatment with
antioxidants,” Toxicology and Applied Pharmacology, vol. 190,
no. 1, pp. 17–24, 2003.
[32] J. L. Tomsig and J. B. Suszkiw, “Permeation of Pb2+ through
calcium channels: fura-2 measurements of voltage- and
dihydropyridine-sensitive Pb2+ entry in isolated bovine
chromaffin cells,” Biochimica et Biophysica Acta, vol. 1069, no.
2, pp. 197–200, 1991.
[33] E.M. Leslie, J. Liu, C. D. Klaassen, andM. P.Waalkes, “Acquired
cadmium resistance in metallothionein-I/II(−/−) knockout
cells: role of the T-type calcium channel Cacn𝛼1G in cadmium
uptake,” Molecular Pharmacology, vol. 69, no. 2, pp. 629–639,
2006.
[34] R. Deane and M. W. B. Bradbury, “Transport of lead-203 at
the blood-brain barrier during short cerebrovascular perfusion
with saline in the rat,” Journal of Neurochemistry, vol. 54, no. 3,
pp. 905–914, 1990.
[35] R. S. Diaz and J. Monreal, “Protein-independent lead perme-
ation through myelin lipid liposomes,” Molecular Pharmacol-
ogy, vol. 47, no. 4, pp. 766–771, 1995.
[36] L. E. Kerper and P. M. Hinkle, “Cellular uptake of lead is
activated by depletion of intracellular calcium stores,” Journal
of Biological Chemistry, vol. 272, no. 13, pp. 8346–8352, 1997.
[37] L. E. Kerper and P. M. Hinkle, “Lead uptake in brain capillary
endothelial cells: activation by calcium store depletion,”Toxicol-
ogy and Applied Pharmacology, vol. 146, no. 1, pp. 127–133, 1997.
[38] M. E. Legare, R. Barhoumi, E. Hebert, G. R. Bratton, R. C.
Burghardt, and E. Tiffany- Castiglioni, “Analysis of Pb2+ entry
into cultured astroglia,” Toxicological Sciences, vol. 46, no. 1, pp.
90–100, 1998.
[39] J. H. Cheong, D. Bannon, L. Olivi, Y. Kim, and J. Bressler,
“Different mechanismsmediate uptake of lead in a rat astroglial
cell line,”Toxicological Sciences, vol. 77, no. 2, pp. 334–340, 2004.
[40] T. J. Evans, M. R. James-Kracke, S. B. Kleiboeker, and S. W.
Casteel, “Lead enters Rcho-1 trophoblastic cells by calcium
transport mechanisms and complexes with cytosolic calcium-
binding proteins,” Toxicology and Applied Pharmacology, vol.
186, no. 2, pp. 77–89, 2003.
[41] G. J. Kaczorowski, R. S. Slaughter, V. F. King, and M. L.
Garcia, “Inhibitors of sodium-calcium exchange: identification
and development of probes of transport activity,” Biochimica et
Biophysica Acta, vol. 988, no. 2, pp. 287–302, 1989.
[42] S. L. Sensi, L. M. T. Canzoniero, S. P. Yu et al., “Measurement of
intracellular free zinc in living cortical neurons: routes of entry,”
Journal of Neuroscience, vol. 17, no. 24, pp. 9554–9564, 1997.
[43] R. A. Colvin, “Characterization of a plasma membrane zinc
transporter in rat brain,” Neuroscience Letters, vol. 247, no. 2-3,
pp. 147–150, 1998.
[44] V. Picard, G. Govoni, N. Jabado, and P. Gross, “Nramp 2
(DCT1/DMT1) expressed at the plasma membrane transports
iron and other divalent cations into a calcein-accessible cyto-
plasmic pool,” Journal of Biological Chemistry, vol. 275, no. 46,
pp. 35738–35745, 2000.
[45] M. Okubo, K. Yamada, M. Hosoyamada, T. Shibasaki, and H.
Endou, “Cadmium transport by human Nramp 2 expressed in
Xenopus laevis oocytes,” Toxicology and Applied Pharmacology,
vol. 187, no. 3, pp. 162–167, 2003.
[46] A. C. Illing, A. Shawki, C. L. Cunningham, and B. Mackenzie,
“Substrate profile and metal-ion selectivity of human divalent
metal-ion transporter-1,” The Journal of Biological Chemistry,
vol. 287, pp. 30485–30496, 2012.
[47] J. P. Bressler, L. Olivi, J. H. Cheong, Y. Kim, A. Maerten, and
D. Bannon, “Metal transporters in intestine and brain: their
involvement in metal-associated neurotoxicities,” Human and
Experimental Toxicology, vol. 26, no. 3, pp. 221–229, 2007.
[48] Z. Liu, H. Li, M. Soleimani et al., “Cd2+ versus Zn2+ uptake
by the ZIP8 HCO
3
—dependent symporter: kinetics, electro-
genicity and trafficking,” Biochemical and Biophysical Research
Communications, vol. 365, no. 4, pp. 814–820, 2008.
